Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-γ

Journal of Lipid Research

Volumn 41, Issue 5, 2000, Pages 688-698

  Feng, Jianwen ^a   Han, Jihong ^a   Pearce, S Freida A ^a   Silverstein, Roy L ^a   Gotto Jr , Antonio M ^a   Hajjar, David P ^a   Nicholson, Andrew C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CD36; Macrophage; PPAR ; Scavenger receptor PKC

Indexed keywords

CD36 ANTIGEN; CYCLIC AMP; DIACYLGLYCEROL; INGENOL; INTERLEUKIN 4; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN DERIVATIVE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TRANSPORT; REACTION ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD36; BASE SEQUENCE; CELL LINE; DNA, COMPLEMENTARY; ENZYME ACTIVATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-4; LIPOPROTEINS, LDL; MICE; MONOCYTES; PROSTAGLANDIN D2; PROTEIN KINASE C; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0034123963     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Steinberg, D. 1987. Lipoproteins and the pathogenesis of atherosclerosis. Circulation 76: 508-514.
2. Steinberg, D., S. Parthasarathy, T. Carew, J. Khoo, and J. Witztum. 1989. Beyond cholesterol. Modifications of low-density lipoprotein which inrease its atherogenicity. N. Engl. J. Med. 320: 915-919.
3. Gown, A., T. Tsukada, and R. Ross. 1986. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125: 191-207.
4. Fogelman, A., B. Van Lenten, C. Warden, M. Haberland, and P. Edwards. 1988. Macrophage lipoprotein receptors. J. Cell Sci. Suppl. 9: 135-149.
5. Pearson, A., A. Lux, and M. Krieger. 1995. Expression cloning of dSR-Cl, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 92: 4056-4060.
6. Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell. 80: 603-609.
7. Ramprasad, M., W. Fischer, J. Witztum, G. Sambrano, O. Quehenberger, and D. Steinberg. 1995. The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of CD68. Proc. Natl. Acad. Sci. USA. 92: 9580-9584.
8. Acton, S., R. Attilio, K. Landschultz, S. Xu, H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
9. Talle, M., P. Rao, E. Westberg, N. Allegar, M. Makowski, R. Mittler, and G. Goldstein. 1983. Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. Cell. Immunol. 78: 83-99.
10. Li, Y. S., Y. J. Shyy, J. G. Wright, A. J. Valente, J. F. Cornhill, and P. E. Kolattukudy. 1993. The expression of monocyte chemotactic protein (MCP-1) in human vascular endothelium in vitro and in vivo. Mol. Cell Biochem. 126: 61-68.
11. Greenwalt, D., R. Lipsky, C. Ockenhouse, H. Ikeda, N. Tandon, and G. Jamieson. 1992. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood. 80: 1105-1115.
12. Ryeom, S. W., R. L. Silverstein, A. Scotto, and J. R. Sparrow. 1996. Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J. Biol. Chem. 271: 20536-20539.
13. Abumrad, N., M. R. El-Maghrabi, E. Amri, E. Lopez, and P. Grimaldi. 1996. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J. Biol. Chem. 268: 17665-17668.
14. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis. J. Biol. Chem. 268: 4569-4572.
15. Endemann, G., L. Stanton, K. Madden, K. Bryant, R. T. White, and A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
16. Nicholson, A., S. F. A. Pearce, and R. Silverstein. 1995. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 15: 269-275.
17. Rigotti, A., S. Acton, and M. Krieger. 1995. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270: 16221-16224.
18. Ren, Y., R. Silverstein, J. Allen, and J. Savill. 1995. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J. Exp. Med. 181: 1857-1862.
19. Asch, A., J. Barnwell, R. Silverstein, and R. Nachman. 1987. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 79: 1054-1061.
20. Tandon, N., U. Kralisz, and G. Jamieson. 1989. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J. Biol. Chem. 264: 7576-7583.
21. Barnwell, J., C. Ockenhouse, and D. Knowles. 1985. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J. Immunol. 135: 3494-3497.
22. Parthasarathy, S., L. Fong, D. Otero, and D. Steinberg. 1987. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the aceytl-LDL receptor. Proc. Natl. Acad. Sci. USA. 84: 537-540.
23. Calvo, D., D. Gomez-Coronado, Y. Suarez, M. Lasuncion, and M. A. Vega. 1998. Human CD36 is a high affinity receptor for the native lipoproteins HDL,LDL and VLDL. J. Lipid Res. 39: 777-788.
24. Connelly, M. A., S. Klein, S. Azhar, N. Abumrad, and D. L. Williams. 1999. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoproteine-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 274: 41-47.
25. Yesner, L., H. Huh, S. F. A. Pearce, and R. Silverstein. 1996. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16: 1019-1025.
26. Han, J., D. P. Hajjar, M. Febbraio, and A. C. Nicholson. 1997. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J. Biol. Chem. 272: 21654-21659.
27. Tontonoz, P., L. Nagy, J. Alvarez, V. Thomazy, and R. Evans. 1998. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93: 211-252.
28. Nagy, L., P. Tontonoz, J. Alvarez, H. Chen, and R. Evans. 1998. Oxidixed LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell. 93: 229-240.
29. Tontonoz, P., E. Hu, and B. Spiegelman. 1995. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 5: 571-576.
30. Fyrnys, B., R. Claus, G. Wolf, and H. P. Deigner. 1997. Oxidized low density lipoprotein stimulates protein kinase C (PRC) activity and expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 cells. Adv. Exp. Med. Biol. 407: 93-98.
31. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
32. Liao, J. K., W. S. Shin, W. Y. Lee, and S. L. Clark. 1995. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324.
33. Kliewer, S. A., B. Forman, U. Blumherg, E. Ong, U. Borgmeyer, U. Mangelsdorf, K. Umesono, and R. M. Evans. 1994. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA. 91: 7355-7359.
34. Nicholson, A. C., D. P. Hajjar, and R. L. Silverstein. 1995. Effect of anti-CD36 antibodies on binding of oxidized LDL to CD36-transfected cells. In Leukocyte Typing V: White Cell Differentiation Antigens. S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, R. L. Silverstein, T. A. Springer, T. F. Tedder, and R. F. Todd, editors. Oxford University Press, Oxford, England. 1278-1280.
35. Taylor, K. T., Y. Tang, D. A. Sobieski, and R. H. Lipsky. 1993. Characterization of two alternatively spliced 5′-untranslated exons of the human CD36 gene in different cell types. Gene. 133: 205-212.
36. Kodama, T., P. Reddy, C. Kishamoto, and M. Krieger. 1988. Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 85: 9238-9242.
37. Via, D., H. Dresel, S-L. Cheng, and A. Gotto. 1985. Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor. J. Biol. Chem. 260: 7379-7386.
38. Parthasarathy, S., D. Printz, D. Boyd, L. Joy, and D. Steinberg. 1986. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis. 6: 505-510.
39. Huh, H-Y., S. F. A. Pearce, L. Yesner, and R. L. Silverstein. 1996. Regulated expiessiorr of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood. 87: 2020-2028.
40. Kashiwagi, H., Y. Tomiyama, Y. Kosugi, M. Shiraga, R. Lipsky, Y. Kanayama, Y. Kurata, and Y. Matsuzawa. 1994. Identification of the molecular defects in a subject with type I CD36 deficiency. Blood. 83: 3545-3552.
41. Nozaki, S., H. Kashiwagi, S. Yamashita, T. Nakagawa, B. Kostner, Y. Tomiyama, A. Nakata, M. Ishigami, J. Miyagawa, K. Kameda-Takemura, Y. Kurata, and Y. Matsuzawa. 1995. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96: 1859-1865.
42. Febbraio, M., N. A. Abumrad, D. P. Hajjar, K. Sharma, W. Cheng, S. F. A. Pearce, and R. L. Silverstein. 1999. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274: 19055-19062.
43. Kliewer, S. A., and T. M. Willson. 1998. The nuclear receptor PPAR gamma - bigger than fat. Curr. Opin. Genet. Dev. 8: 576-581.
44. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83:803-812.
45. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkinson, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ). J. Biol. Chem. 270: 12953-12956.
46. Ricote, M., A. Li, T. Wilson, C. Kelly, and C. Glass. 1998. The peroxisome proliferator-activaled receptor-gamma is a negative regulator of macrophage activation. Nature. 391: 79-82.
47. Ricote, M., J. Huang, L. Fajas, A. Li, J. Welch, J. Nijab, J. Witztum, J. Auwerx, W. Palinski, and C. Glass. 1998. Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 95: 7614-7619.
48. Huang, J. T., J. S. Welch, M. Ricote, C. J. Binder, T. M. Willson, C. Kelly, J. L. Witztum, C. D. Funk, D. Conrad, and C. K. Glass. 1999. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature. 400: 378-382.
49. Via, D., L. Pons, D. Dennison, A. Fanslow, and F. Bernini. 1989. Induction of arcetyl-LDL receptor activity by phorbol ester in human monocyte cell line THP-1. J. Lipid Res. 30: 1515-1524.